A Study to Assess the Feasibility of Folate Scan in Patients with Idiopathic Pulmonary Fibrosis

Overview

About this study

The purpose of this study is to assess the feasibility of Folate scan in patients with Idiopathic Pulmonary Fibrosis (IPF).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Clinical/Radiological/Pathological diagnosis of IPF
Signed informed consent
Age >= 18 years
Not required: Scheduled to undergo or recently underwent diagnostic lung biopsy or scheduled for lung transplantation (we will preferentially invite patients to participate in this study if they are scheduled to undergo a clinically indicated lung biopsy or lung transplantation)

Exclusion Criteria

Immunosuppressive therapy (> 5 mg/day of Prednisone or inhaled corticosteroids)
Pregnancy or breast feeding
Subject is mentally incapable of understanding study procedures.
Patient is unable to tolerate the conditions for radionuclide imaging

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Tobias Peikert, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Tobias Peikert, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials